ArticleBiomedicines2025

Last Resort? Rationale for Comprehensive Molecular Analysis in Treatment-Refractory R/M HNSCC: A Case Report of Remarkable Response to Sacituzumab Govitecan Following Molecular and Functional Characterization.

Henrike Barbara Zech et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.